VCG
GILD icon

Vantage Consulting Group’s Gilead Sciences GILD Stock Holding History

Vantage Consulting Group’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-3,577
Closed -$245K – 70
2024
Q2 		$245K Buy
3,577
+415
+13% +$27.7K 0.18% 100
2024
Q1 		$232K Buy
3,162
+198
+7% +$15.2K 0.15% 154
2023
Q4 		$240K Sell
2,964
-86
-3% -$6.69K 0.16% 142
2023
Q3 		$229K Buy
3,050
+108
+4% +$8.31K 0.15% 145
2023
Q2 		$227K Sell
2,942
-69
-2% -$5.5K 0.13% 174
2023
Q1 		$250K Buy
3,011
+265
+10% +$21.9K 0.14% 157
2022
Q4 		$236K Sell
2,746
-1,193
-30% -$94.5K 0.14% 149
2022
Q3 		$243K Sell
3,939
-22
-0.6% -$1.39K 0.14% 130
2022
Q2 		$245K Buy
3,961
+4
+0.1% +$248 0.14% 136
2022
Q1 		$235K Buy
3,957
+259
+7% +$16.6K 0.09% 170
2021
Q4 		$269K Buy
3,698
+265
+8% +$18.3K 0.07% 157
2021
Q3 		$240K Buy
3,433
+133
+4% +$9.34K 0.05% 148
2021
Q2 		$227K Buy
+3,300
New +$220K 0.04% 172
2021
Q1 		– Sell
-1,199
Closed -$70K – 676
2020
Q4 		$70K Buy
+1,199
New +$72.3K 0.01% 315

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Vantage Consulting Group's GILD Position: Q3 2024 in Review

Vantage Consulting Group sold out of Gilead Sciences (GILD) in Q3 2024, closing a stake of 3,577 shares — an estimated $245K sold.

Vantage Consulting Group first reported a position in GILD in Q4 2020 and held it in 14 quarters. The position peaked at $269K in Q4 2021. 1,718 funds tracked by Wall St. Rank hold GILD as of Q3 2024.

  • Vantage Consulting Group reported no remaining Gilead Sciences position as of Q3 2024 after selling out during the quarter.
  • Vantage Consulting Group sold 3,577 Gilead Sciences shares in Q3 2024, an estimated $245K.
  • Vantage Consulting Group first reported a position in Gilead Sciences in Q4 2020 and held it in 14 quarters.
  • Vantage Consulting Group's Gilead Sciences position peaked at $269K in Q4 2021.
  • 1,718 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2024.

Based on Vantage Consulting Group's 13F filing for Q3 2024, filed 14 Nov 2024.